Association for Research in Vision and Ophthalmology Winter Newsletter 2004

Annual Meeting A MESSAGE FROM THE PRESIDENT GARY W. ABRAMS, MD Highlights New Meeting t its meet- reimbursement in clinical medicine Schedule ing in and increasing competition for Visit www.arvo.org to see specific AOctober, research grants. Dr. Robert Weinreb, schedule and make your travel The Association in a symposium at the annual meet- plans accordingly. for Research in ing of The Association of University Keynote Session Vision and Professors of Ophthalmology (AUPO) ARVO is honored to host two dis- Ophthalmology in January, 2004, spoke on the tinguished speakers at the 2005 (ARVO) Board of importance of the clinician-scientist Keynote Session. NIH Director, Trustees discussed several issues as part of the research enterprise. He Elias A. Zerhouni, and acclaimed directly impacting the present and proposed the question, "Are clini- Nobel Laureate, Peter Agre will future nature of our organization. cian-scientists needed?" He answered that "clinician-scientists are vitally speak on Sunday night. Disciplines vs. Specialties important and necessary in order to Wireless Internet Access Many of the older discipline-based identify clinically relevant questions In addition to expanded free secure Sections are experiencing a decline in to answer in the laboratory, solve Internet access in the ARVO membership. Contributing to this problems through rigorous clinical Internet Suite and Cyber Café, decline has been a shift over the years investigation, and translate laboratory Wireless Internet hot spots will be at ARVO (and in training programs discoveries into new methods for located in designated areas of the in general) away from disciplines diagnosis, prevention, and treatment Convention Center. Refer to the (anatomy, bio- of eye disease. Meeting Update for locations and chemistry, “With a strong, stable membership, They are access information, and look for physiology, exceptional financial position, and dedi- needed to signs in the Convention Center etc.) to more cated volunteers, we are prepared mentor the identifying the hot spots. integrative pro- [for]... a rich future,” next generation ARVO Social in Exhibit Hall grams. A shift ARVO President, Gary W. Abrams, MD of clinician-sci- The popular ARVO Social on away from discipline-based programs entists, fill the Sunday, May 1, will be located in to integrated programs has also void between the laboratory and the Hall B/C and exhibitors will be occurred in graduate training in the clinic, and to articulate and advocate available at their booths. biomedical sciences. Most institu- the clinical relevance of basic and ARVOJobs and Career Fair translational research." Elias tions have dropped discipline degree On Tuesday, from 12:00 PM - Zerhouni, the director of the offerings in favor of more integrated 4:00 PM, you will have the oppor- programs. Are ARVO discipline National Institutes of Health (NIH) tunity to speak with representatives Sections outdated? ARVO must eval- has noted that "…exciting basic sci- from industry, academia, and gov- uate whether there is a better way to ence discoveries demand that clinical ernment about opportunities with represent Sections so that we move to research continue and even expand, their organizations at the ARVO a more integrated approach in the while striving to improve efficiency Career Fair, located in the future. A working group of past and better inform basic science." Registration area, adjacent to the ARVO Trustees is looking closely at Among NIH initiatives to expand the ARVOJobs Placement Center.n this issue and other key aspects of clinical enterprise will be increased ARVO’s governance as we position efforts to provide advanced training IN THIS ISSUE the Association for the future. in clinical research through existing ARVO Elections ...... 2 and new programs to train clinician- Letter to Members on Open Access . . . .4 scientists and new programs aimed at Clinician Scientist Committees ...... 6 "Endangered Species" institutions and clinical centers. ARVO Advocacy & NEI/NIH News . . .7-10 The clinician-scientist faces many ARVO has the opportunity to join JOV ...... 12 challenges in a time of declining with the AUPO and the NIH to raise President’s Message continued on page 3 IOVS ...... 13 ARVOELECTIONS

2004 - 2005 2005 Trustee Election Officers ll voting members (Regular, Family, Sustaining, Life, and Family Life) of the Retina Gary W. Abrams, MD A(RE) and Physiology and Pharmacology (PH) Sections will elect Trustees in 2005 at President their Sections Business Meeting in Fort Lauderdale. Proxies and candidate information will Thomas Yorio, PhD be distributed in February, 2005. Vice President PHYSIOLOGY AND PHARMACOLOGY RETINA Larry J. Takemoto, PhD Nicholas Delamere, PhD Paul Sternberg, MD University of Louisville Vanderbilt University Medical Center President-Elect M. Christine McGahan, PhD Yasuo Tano, MD Joel M. Miller, PhD North Carolina State University Osaka University Medical School Vice President-Elect Proxies may be registered online or mailed to the ARVO Office. Advance proxies must be Steven E. Wilson, MD registered by April 18, 2004. Instructions for both methods of registering your proxy will be Vice President-Elect included in the election mailing. Proxies may also be cast in person or amended in the 15- minute period preceding the Section Business Meeting. Election results will be announced Sally S. Atherton, PhD in the corresponding Section's Business Meeting.n Immediate Past President Paul L. Kaufman, MD Sections to Nominate Trustees in 2005 Executive Vice President At their Sections’ Business Meeting, the following Sections will nominate candidates for Trustee: • Cornea (CO) • Eye Movements, Strabismus, Amblyopia and Neuro-Ophthalmology (EY) ARVO Office • Lens (LE) Joanne G. Angle The ARVO Bylaws stipulate that "each standing Scientific Section whose Trustee's term of Executive Director office will expire at the end of the following year's Annual Meeting shall nominate no Kimberly M. O’Sullivan more than two (2) candidates, one of whom will be elected as the Successor Trustee at the following year's Scientific Section's separate business meeting, which will take place at the Publications Coordinator Annual Meeting." 12300 Twinbrook Parkway, Suite 250 Rockville, MD 20852-1606 All members are encouraged to consider who will best represent their Sections in this Phone: (240) 221-2900 important role.n Fax: (240) 221-0370 Volunteer Today For An ARVO Committee

RVO committees are active in many the only face-to-face meetings typically Aareas; developing programs, enhancing occurring in conjunction with the ARVO member services, assisting the Board of Annual Meeting making participation by Trustees in the leadership of the Members outside the US possible and Association. Each year, ARVO members convenient. have the chance to express interest in serv- To be considered for appointment, visit ing on a committee and playing a more the committees page under "About ARVO" active role in filling these critical committee on the ARVO Web site. Here you can view functions. Service on an ARVO committee committee descriptions and learn more will bring you close to the inner-workings about the work of the committees. A of the Association, providing opportunities Volunteer form can be found on the Web There is still time to become a for personal and professional development site at the committee main page and on member of ARVO, renew your and advancement. each committee's individual page. All indi- membership or register for the Appointments to ARVO committees are viduals completing this form online will be 2005 Annual Meeting – made each year by the President-Elect. considered for appointment in 2005. New committee appointees are encouraged To learn more about committee partici- Global Networking! to attend committee functions at the pation, you may also contact ARVO Annual Meeting prior to the commence- Director of Governance and Strategic www.arvo.org ment of their terms at the close of the Initiatives Robert Rupp at [email protected] Annual Meeting. Throughout the year, or 240-221-2912.n committees meet via conference call, with 2 www.arvo.org RVO is redesigning its Web site and we ! ted Aneed your help. We are looking for Calendar an reviewers to provide guidance and feedback on W the new design and functionality. To sign up Important Dates and elp H to be a reviewer or to find out more, please Upcoming Events contact TJ Rainsford, director of technology & web services, at [email protected] 2005 January 21-22 Program Committee Meeting President’s Message continued from page 1 January 25 DEADLINE for Abstract awareness of issues facing clinician-scientists. ARVO has embarked on a series of initiatives Withdrawal (if withdrawn to recognize clinician-scientists in training, provide career development information to new after this date, abstract(s) will still appear in Meeting and budding clinician-scientists, advocate for development of a mechanism to provide publications bridge funding for young clinician-scientists during the K award development process, February 24 Notification of Abstract promote communication among clinician-scientists at all stages of development and pro- Acceptance and mote international development of clinician-scientists. (More information on page 8). Abstract Search Program available at www.arvo.org International Outreach March 4 DEADLINE for 2006 The global funding needs for eye and vision research are significant and are growing every ARVO Awards day. An important initiative that has come from the strategic planning process is the need Nominations for international advocacy for research funding. The most successful strategy for persuad- April 1 DEADLINE for Online ing governments to increase research funding may be to develop a program supported by Housing Reservations individuals and industry that convinces these governments that research funding is a wor- April 8 DEADLINE for Early thy investment. In addition, it is also important to collect enough data to explain how Registration Fees socio-economic factors will mitigate the cost of funding research in a given country or set- April 22 DEADLINE for Annual ting; making the case for governments and funding agencies that the growing incidence of Meeting Advance vision loss and blindness are too costly a crisis to ignore. Registration A key component to this strategy is assembling cadres of researchers in their own coun- DEADLINE for ARVO tries willing to promote the value of vision research and work in their country to secure Courses Registration industry and governmental funding. Already groups of ARVO members in some countries, www.arvo.org including Argentina, Brazil and Israel have formed independent national research organiza- April 27 DEADLINE for Advance tions. The Board feels that these organizations have great potential to serve as the founda- Registration Refund tion for the formation of international ARVO chapters in the not-so-distant future. Requests (must be made in Questions remain as to the formal model that would be most effective and how chapters writing and accompanied would formally relate to ARVO, but it is clear that chapters will have significant impact on by namebadge.) promoting vision research, generating much needed funding, and increasing the opportu- April 29 - 30 Vision Research Conference nities for active involvement in ARVO. April 30 ARVO Education Finally, the Board considered the nomination process for Trustees. This process has var- Courses: Nanotechnology ied among Sections over time. In order to assure representation of all Section members, and Nanomedicine: including international members, a working group made up of current and former Applications for Vision Trustees and Section Program Chairs will evaluate and make recommendations on improv- Research 1:00 PM - 4:00 PM ing current processes by increasing participation and inclusiveness for all ARVO members. Ocular Oncology The excitement of the Board in its discussion of these issues was particularly reassuring Collaborative Research to me, not only in my role as President, but also as an ARVO Member. With a strong, sta- 8:20 AM - 4:00 PM ble membership, exceptional financial position, and dedicated volunteers at all levels of the May 1 - 5 ARVO Annual Meeting, Association, we are prepared to face these issues and address them with solutions that will Fort Lauderdale, Florida build on ARVO's strong history, and lead to a rich future.n September Ocular Cell and Molecular 8-10 Biology: Summer Eye Research Conference Sincerely, Sarasota, Florida September Regenerative Ocular Biology: 25-28 Western Eye Research Gary W. Abrams, MD Conference ARVO President Laguna Beach, California

www.arvo.org 3 LETTERTO A RVO MEMBERS ON OPEN ACCESS

n November you received a letter from the Board of Trustees provide a partial picture of the research to both scientists and Iurging you to comment on the National Institutes of Health the public. More than 50 percent of articles published in (NIH) Notice on Public Access. We thank you for sending your Investigative Ophthalmology & Visual Science (IOVS) and Journal comments regardless of whether you supported the Notice or of Vision (JOV) report funding support from NIH. In addition, agreed with the delay of implementation until more informa- the process by which the author's version of the accepted manu- tion is available. This is a complex issue with potentially wide script and the final published version of the article would be ranging effects on all of us. The comment period has closed and provided and linked has not been described. We are concerned there are some indications that a decision on how NIH will that with electronic file processing and changes that are fre- proceed may be forthcoming. Watch the ARVO Web site for quently made during the editing and production process, the updates. author’s manuscript may not match the published article of A brief history of what prompted the recent activities may record. Also, the author’s version may be available through clarify the issue. In July the US House of Representatives PubMed Central before the published article which could lead Appropriations Committee issued a report recommending that to confusion. We believe that the final published version should NIH develop a policy for all arti- “We are concerned that with electronic file processing and be the article of record since it has cles for which grant funds are used changes that are frequently made during the editing and been copy edited, the references to pay publication charges and production process, the author’s manuscript may not match have been checked, and the article verified again through proofs read making those articles available no the published article of record,” by the author. later than six months after publica- ARVO President, Gary W. Abrams, MD tion through PubMed Central. The There is also concern about the House report called for a full report from NIH to the Committee financial impact on journals. ARVO has three primary sources of by December 1 about how NIH intends to implement the policy income: dues; subscriptions; and author fees. This revenue must that will apply from Fiscal Year (FY) 2005 forward. cover the costs of peer review, copy editing, file preparation, print- Between August 15th and 29th NIH arranged three meet- ing, and mailing as well as contributing to the other ARVO bene- ings with different groups potentially affected by the policy: fits and programs. If any of these sources of revenue is reduced, intra- and extramural scientists; publishers; and patient advo- there will be two choices only: raise dues and fees or reduce pro- cacy groups. All constituents were invited to voice concerns and grams and journal pages. Currently more than 1,700 articles are submit their suggestions about the US House requirements. submitted each year; due to the rigorous review and high quality ARVO participated in the discussions and sent a letter to Dr. standards, less than 850 are accepted and published. Elias Zerhouni, director, NIH, expressing concerns that more ARVO currently deposits all IOVS and JOV abstracts in information about the plan and its implementation would be Medline provides links back to the published articles of record. needed before a complete response would be possible. We The IOVSOnline articles are protected from potential misuse requested a delay until more information was available. The and all articles are stored in a "deep" or protected archive that Notice referred to in our email to you was published on the can be updated to meet the needs of ever changing technolo- NIH site on Friday, September 3 and in the Federal Register on gies. This archive is at Stanford University Library, which is one September 17 and the deadline for sending comments to NIH of the highly regarded, secure repositories recommended by was extended to November 16. librarian's world wide. ARVO currently makes IOVS articles Associations, private publishers, advocacy groups, and indi- freely accessible 12 months after publication and articles from viduals submitted "thousands" of comments according to David the free access JOV are open and freely accessible from the time Lipman, director, National Center for Biotechnology of publication. Information at the National Library of Medicine. All comments On November 20, the House of Representatives passed the are being reviewed and categorized now and a question and 2005 Appropriations Bill and included the following statement: answer site is being built to address the concerns and finalize "NIH is directed to give full and fair consideration to all com- the policy. ments before publishing its final policy. The conferees request The NIH has three stated goals that the policy is designed NIH to provide the estimated costs of implementing this policy to meet: each year in its annual Justification of Estimates to the House and • Creating a stable archive of peer-reviewed research publi- Senate Appropriations Committees. In addition, the conferees cations to ensure the permanent preservation of these vital direct NIH to continue to work with the publishers of scientific published findings; journals to maintain the integrity of the peer review system." • Securing for NIH a searchable compendium of peer- ARVO looks forward to participating in these discussions and reviewed research publications that the agency can use to working with NIH and all stakeholders to develop an equitable manage its research portfolio and monitor scientific pro- and reasonable solution and is willing to provide open access to all ductivity; and articles six months after date of publication.n • Giving the public better access to a time-delayed archive of published results of NIH-funded research. The goals illustrate several of our concerns: as defined, this archive would result in only part of the peer reviewed and accepted articles stored in the archive since there is no accom- Gary W. Abrams, MD modation for those articles not funded by NIH. This would ARVO President

4 www.arvo.org ARVOMEMBERSHIP NEWS

Brain Awareness Week – March 15 - 21, 2005 Member Discounts rain Awareness Week is an interna- tional activ- on Btional effort organized by the Dana ity high- Vision-Related Journals Alliance for Brain Initiatives to advance lighting the public awareness about the progress, wonders of A RVO members are entitled to discounted subscriptions to a variety promise, and benefits of brain research. the brain of professional journals. To take The Dana Alliance is joined in the and nervous advant age of this member benefit, campaign by partners in the United system. go to w w w .arvo.org/Membership/ States and around the world, including Take part in the tenth annual cele- DiscountJournals.asp. medical and research organizations; bration of Brain Awareness Week, and patient advocacy groups; the National visit their Web site at American Orthoptic Institutes of Health, and other govern- www.dana.org/brainweek for informa- Binocular V ision & ment agencies; service groups; hospitals tion to help you plan programs during S trabismus Surgery and universities; K-12 schools; and Brain Awareness Week, including advice Quarterly professional organizations. on finding a speaker, developing ideas Current Eye Research Your organization or institution is for activities and events, and communi- European Journal of invited to host a special event or educa- cating neuroscience to the public.n Ophthalmology Graefe’s Archive www.dana.org/brainweek Neuro-ophthalmology Ocular Immunology The Ocular Surface Ophthalmic Epidemiology Please Confirm Your E-mail Address! Ophthalmic Genetics Ophthalmic Research Ophthalmologica Orbit re you receiving e-mails from ARVO? If not, we need your correct e-mail Perception address! Check the online Member Directory at www.arvo.org and update your A S trabismus e-mail address or e-mail us at [email protected]. Vision Research With e-mail addresses for more than 90 percent of our members, this has V isual Neuroscience become our primary method of communication. If we do not have your correct e-mail address, you may not receive notification If there are additional journals you regarding abstract submission or updated Annual Meeting information.You will would be interested in receiving at a not get spammed by ARVO! We do not permit our e-mail list to be used by out- discount, please forward the name side organizations. Update your e-mail address today and do not miss any more of the publication to [email protected], important announcements and reminders.n and we will cont act the publisher about p articipating in this member benefit program. n

ARVOJobs! – New Enhanced Job Site http://jobs.arvo.org

e are pleased to announce the new ARVOJobs Web site Employers: Wthat includes the following features. ·Searchable CV database · Enhance listing with logos, institutional profiles, Job Seekers (post your CV for FREE): Web site links · Job Seeker privacy · Register different criteria for different jobs and receive · Posting of CVs, cover letters and other documents E-mail notification when matching CVs are posted · Job Search engine with multiple criteria including · Job management info including number of times keyword, category, level, location, etc. position is viewed, number of online applications, etc.n · Online application process · Registration for notification when jobs matching your criteria are posted · Activity reports of institutions applied to, number of Check it out TODAY! time their CV has been viewed, etc. http://jobs.arvo.org www.arvo.org 5 NEWSFROM COMMITTEES

ARVO Represented at AAALAC Board Meeting ARVO Animals in Research Committee Chair Jeff AAALAC as needed. The European use the "Agricultural Guide for the Kiel, PhD, serves as ARVO's delegate to the Board Section Council anticipates needing Care and Use of Animals" (the "Ag of Trustees of the Association for the Assessment and approximately 20 ad Hoc site visitors Guide) which differs significantly from Accreditation of Laboratory Animal Care to fulfill their mission. the Guide for the Care and Use of International (AAALAC). Dr. Kiel reported on the The goal of the European Section Laboratory Animals (the "Guide"). following outcomes from the AAALAC Board Council is to increase the number of Also, agricultural animals do not always Meeting held in September. accredited institutions in Europe. fall under the jurisdiction of the AAALAC anticipates that European Animal Welfare Act or the United New European Section Council funding agencies may soon require States Department of Agriculture. This AAALAC has created a new European accreditation, as may the European will be a significant evolution for Section Council on Accreditation. The Union. However, harmonization of reg- AAALAC.n European Section is comprised of nine ulations governing research animal use CONCERNED European members and is responsible in Europe is not likely soon. ABOUT ANIMAL USE ISSUES? for performing accreditation site visits AAALAC is promoting accreditation in Europe. The European Section in Asia (Singapore, India, China, received training on how to perform Korea), South America, and South The ARVO Animals in site visits by the North American Africa and is also in the early stages of Research Committee monitors Section Council in September, and met offering accreditation for agricultural the global regulation of animals on their own in Brussels recently. facilities overseas. used in ophthalmic research. Applications and institutional self- Visit the Web site, reports as well as supporting documen- Agricultural Research Programs www.arvo.org/Committee/ tation from an institution can be in AAALAC is expanding into accredita- AnimalsInResearch/ English, or the native language of the tion of North American Agricultural animalresearch.asp for more institution with translation provided by Research Programs. Such site visits will information.

A RV O Committee Sponsored Attention: Students, W orkshops During 2005 Post-Docs and FIRST ONLINE COMMUNITY Annual Meeting Fellows LAUNCHED BY THE MEMBERS-IN-TRAINING COMMITTEE CAREER DEVELOPMENT THROUGH NETWORKING AND COLLABORATIONS Organized by the Members-in-Training Committee Sunday, May 1 1:00 PM - 2:30 PM

CASE STUDIES IN INTELLECTUAL PROPERTY: PROTECTING YOUR IDEA Organized by the Commercial Relationships Committee Sunday, May 1 1:00 PM - 2:30 PM

CURRENT ANIMAL WELFARE ISSUES AND ARVO MEMBER RESEARCH Organized by the Scientists Center for Animal www.arvo.org/community/mit Welfare in Cooperation with the Animals in Research Committee CHECK OUT YOUR NETWORKING RESOURCE Sunday, May 1 1:00 PM - 2:30 PM

ETHICAL ISSUES IN RESEARCH PUBLICATION • MIT e-Forum – sign up for this interactive listserve Organized by the Committee on Ethics and Regulation in Clinical Research Pose and respond to questions about all the issues facing you Monday, May 2 1:15 PM - 2:45 PM • Online Library of Resources – documents and links • Under Construction - calendar of MIT events

6 www.arvo.org ARVOADVOCACY

Congress Passes Fiscal Year 2005 Spending Bill; Includes Increase for Medical Research Funding n November 20, Congress passed funding level of $28.4 billion, reflect- They are making a cost-effective invest- Othe Fiscal Year (FY) 2005 ing a net 2 percent increase over FY04. ment that will result in treatments and Omnibus spending bill, which was a This amount does not reflect program therapies to delay or prevent the onset series of nine appropriations bills transfers that could additionally affect of disease and improve the quality of including that for Labor, Health and the net. life for all Americans." Human Services, and Education, con- The appropriated amount for the While acknowledging that the solidated under HR4818, the Foreign National Eye Institute (NEI), prior to FY2005 appropriated level for the NEI Operations appropriations bill. To pay the .83 percent cut, is $674.6 million, is still only 94 percent of the NEI for any additional spending, the bill which is $21.5 million more than the budget-doubling goal of $711 million included a .83 percent across-the-board final programmatic amount of $653 (to bring it into parity with the cut to the appropriated amounts for all million in FY04 and reflects a 3.3 per- budget-doubling that occurred overall non-defense, non-homeland security cent increase. Applying the .83 percent at the NIH from FY1998-FY2003), spending. cut to the NEI appropriated amount, NAEVR Executive Director James The the FY05 NEI increase nets to $669.5 Jorkasky said that the Appropriators' appropriated million, reflecting a net 2.6 percent actions were a "significant step to close amount for increase over FY04, prior to program the gap in eye and vision research the National transfers that could additionally affect funding" but added that, "since federal Institutes of the net. vision research spending is still less Health Commenting on Congress' actions, than one percent of the annual eco- (NIH), the National Alliance for Eye and nomic and societal cost of vision prior to the Vision Research (NAEVR) president impairment of $68 billion, NAEVR .83 percent cut, is $28.6 billion, which and ARVO member Stephen J. Ryan, will continue to advocate for comple- is $800 million more than in FY04 and MD stated, "Given the tight fiscal tion of the NEI budget-doubling to reflects a 2.8 percent increase. Applying environment, we commend the $711 million to deal with this major the .83 percent cut to the NIH appro- Appropriations leaders from both sides public health problem."n priated amount, the FY05 increase nets of the aisle for ensuring increases in to about $560 million or an FY05 federally-funded medical research. ARVO Members Key to Capitol Hill Advocacy Efforts

s Congress grappled with the Fiscal Year 2005 budget advocate); and Senator Stevens, Senate Appropriations Aand appropriations process in the last half of 2004, Committee chair (Native American health issues advocate). members of the ARVO community were effective advocates On September 8, ARVO member Alan Marmorstein, for eye and vision research funding on Capitol Hill and in PhD hosted a district staff member, Sami Hamed, from the Congressional districts. Some examples appear below. office of Congressman Raul Grijalva for a briefing on the On July 14, ARVO member Neil Bressler, MD met with NEI sponsored Early Treatment of Retinopathy of key Members of the Maryland delegation, as well as Prematurity (ETROP) study, presented by study chair and Appropriations leaders, sharing with them the new National ARVO member William Good, MD. Mr. Hamed is sight- Alliance for Eye and Vision Research (NAEVR) developed impaired due to ROP. Age-related Eye Disease fact sheet, available on On September 8, after Rohit Varma, MD and Mildred www.eyeresearch.org. While advocating overall for additional Olivier, MD finished speaking at the Alliance for Eye and National Eye Institute (NEI) funding, Dr. Bressler tailored Vision Research-sponsored his message to the concerns of Vision Health Disparities each office, for example: Senator Research Briefing (see page Sarbanes (children's vision, as his 8), they met with key health legislative assistant is a Appropriations staff just as pediatrician); Senator Mikulski the Senate Labor, Health (an Appropriator and and Human Services, and women's/aging health advocate); Education Subcommittee Congressman Cummings (vision markup was being finalized- health disparities, as Congressman which was approved the next Left to right: Dr. Rohit Varma and Dr. Left to right: Dr. Neil Bressler meets with Cummings chairs the day and recommended Mildred Olivier meet with Brent Jaquet of Liz Connell and Rachel Dallin of Senator Congressional Black Caucus); higher funding for the the office of Congressman Bill Young, chair Ted Stevens’ office. Ms. Dallin’s brother is Congressman Hoyer (an National Institutes of of the House Appropriations Committee sight-impaired due to retinitis pigmentosa Appropriator and aging Health overall, and NEI, continued on page 10 www.arvo.org 7 NEI/NIHNEWS

Research!America Releases New Fact Sheet CLINICIAN SCIENTIST DEVELOPMENT PROGRAMS n early December 2004, Research!America (R!A) and The Lasker Foundation Ireleased a new fact sheet, Vision and Blindness, developed in conjunction with the National Alliance for Eye and Vision Research (NAEVR). This is the first- The National Eye Institute has awarded ever vision-related fact sheet within the R!A portfolio of position papers showcas- several K12 grants for programs for indi- ing how investment in research saves lives and money – especially that sponsored viduals wishing to develop careers as clini- by the National Eye Institute. The fact sheet accompanied the December R!A cian-scientists in vision research. The newsletter which also featured NAEVR as its "Member of the Month." Wilmer Eye Institute and Harvard are seek- The fact sheet's official release on Capitol Hill and to the media will occur in ing applicants for these programs. For January 2005 with the start of the 109th Congress and the Fiscal Year 2006 additional information about the Wilmer appropriations process. "We are pleased to have worked with R!A to expand the Eye Institute program at Johns Hopkins, message about the value of eye and vision research," stated NAEVR Executive see www.wilmer.jhu.edu, or contact Pat Director James Jorkasky, "as it adds another powerful Tracey at [email protected]. For informa- resource to our advocacy efforts with the new Congress." tion on the Harvard program, contact The fact sheet is available at www.researchamerica.org Cori O'Brien at and www.eyeresearch.org.n cori_o'[email protected] Los Angeles Latino Eye Study Issues; Principal Investigator Speaks at Capitol Hill Briefing on Vision Health Disparities Research

n August 9, the National Eye Institute released the Prevalence rates of visual impairment in Latinos are Oresults of the Los Angeles Latino Eye Study (LALES), higher than those reported in Whites and comparable to the largest, most comprehensive epidemiological analysis of those reported in African Americans," said Varma, who added visual impairment in Latinos conducted in the United States. that "given that Latinos are the fastest growing segment of the Co-sponsored by the National Center on Minority Health US population, we are facing a significant increase in the bur- and Health Disparities and Research to Prevent Blindness, den of eye disease as the population ages." He also noted that the study showed that Latinos had high rates of low vision, one in five individuals with diabetes was newly diagnosed dur- open-angle glaucoma and diabetic retinopathy. Full study ing the LALES clinical exam, and 25 percent of these were results appeared in the June, July and August 2004 issues of found to have diabetic retinopathy. Overall, almost half of all the journal Ophthalmology. Latinos with diabetes had diabetic retinopathy. On September 8, LALES Principal Investigator and Acknowledging that African Americans are three times as ARVO member Rohit Varma, MD, MPH was joined by likely to have glaucoma as Whites, Dr. Olivier reported that ARVO member Mildred Olivier, MD, FACS during a the OHTS study found that daily pressure-lowering eye Capitol Hill Briefing on Vision Health Disparities Research, drops reduced the development of primary open-angle glau- sponsored by the Alliance for Eye and Vision Research coma in African Americans by almost 50 percent. "The (AVER) and attended by more than 70 Congressional staff. OHTS study is not only important because it confirmed While Dr. Varma reported on the recent LALES results, Dr. that the risk for developing glaucoma is higher in African Olivier reported on the use of pressure-reducing drops to Americans," said Olivier, "it was also the first study to recruit delay or prevent glaucoma in African Americans in a subset large numbers of African Americans to examine the benefit analysis of the larger Ocular Hypertension Treatment Study of eye drops to delay or prevent its onset." (OHTS). In opening comments, AVER’s James Jorkasky thanked the Congressional Hispanic Caucus for sending a "Dear Colleague" letter to Hill offices supporting the event.n REQUEST FOR APPLICATIONS

D IABETIC C OMPLICATIONS Collaborative Studies on Angiogenesis and Diabetic Complications, will provide up to $3 million to fund five to ten new R01 awards with project periods ranging from two to four years. Letters of Intent due February 17, 2005. Complete det ails regarding this Request for Applications can be found at: http://grant s.nih.gov/grant s/guide/rfa-files/ Left to right: AEVR Executive Director James Jorkasky; Saul Pena of R FA-DK-04-022.html. Congressman Ciro Rodriguez’s office; Jennifer Grodsky of Congresswoman Hilda Solis’ office; and Dr. Rohit Varma (Doheny Eye Institute) 8 www.arvo.org NEI/NIHNEWS

Vision Public Information Network he National Eye Institute (NEI) grantee institutions If you plan to release the Tacross the country participate in the NEI's VISION results of NEI-funded Public Information Network. The Network now has 202 research, check with your members representing 85 eye institutes and departments of public information officer to ophthalmology, 16 schools and colleges of optometry, and 11 see if your institution is rep- affiliated organizations. resented in the Network. He Network members play an important role in disseminat- or she can work with the NEI to help maximize media cover- ing research results through the media. In 2004, the NEI age for your institution, feature the contributions of your sci- released the results of the following studies with the assis- entists, and highlight the benefits of vision research. tance of 36 Network member institutions and Study Centers Additional details and a listing of member institutions are in 18 states. available on the Network Web site at • Los Angeles Latino Eye Study www.visionnetwork.nei.nih.gov. • Ocular Hypertension Treatment Study-African For more information, please contact Jean Horrigan at American Results [email protected] • Prevalence of Blindness Data • Vision in Preschoolers Study

Participation of Women in NEI Extramural Grant Programs

his past summer, members of the success rate was 37 percent for women that the NEI should continue its time- TNational Advisory Eye Council and 34 percent for men. tested policies of grant review and (NAEC) asked National Eye Institute There is evidence for a "glass ceil- award. Council urged NEI to explore (NEI) staff to report on the participa- ing" for women with regards to being policies and outreach programs that tion of women in the Institute's extra- Principal Investigator (PI) on certain might increase the number of women mural grants programs. Starting from who apply for funding. To help address 1970, when only 12 women submitted “glass ceiling” issues, Council noted any type of grant application to NEI, that the vision research community as a the number of women applicants has whole needs to do more to promote risen steadily over the years. By Fiscal women to higher leadership positions. Year 2003, the number of women NEI wishes to highlight a program applying had risen to 303. This repre- designed to support women who wish sents 25 percent of the total number of to reenter an active research career after applicants for that year, a percentage taking time off to care for children or which is identical to that of the NIH as attend to other family responsibilities. a whole. The "Supplements to Promote Reentry types of NEI funding. Women are less into Biomedical and Behavioral likely to be the PI for large, complex Research Careers" provide salary, fringe grant mechanisms, such as the institu- benefits, and up to $10,000 in tional training grants or center core research-related costs for an individual grants. Only 11 of 85 such PIs (13 per- to become a full participant in an cent) are women. Women are also ongoing, NEI-funded research project. under-represented as PIs for large, col- Applications for this program are brief laborative grant activities such as Study and are reviewed administratively Chairs of Phase III clinical trials, under an expedited process (typically Bioengineering Research Partnerships, four to six weeks). Details are available Although the number of women or Collaborative Research on Therapy at http://grants2.nih.gov/grants/guide/ submitting applications is lower than for Visual Disorders. pa-files/PA-04-126.html. Interested that of their male colleagues, women The NAEC examined this data at individuals are urged to contact Dr. are funded at approximately the same their September 2004, meeting and Ralph J. Helmsen, research resources rate as men. Both genders have had made observations and suggestions for officer, at 301-451-2020, or via E-mail essentially equivalent success rates since the NEI staff. It is obviously gratifying at [email protected] the early 1970s with small year-to-year that there is no evidence for discrimi- fluctuations. In Fiscal Year 2003, the nation in success rates for women, and www.arvo.org 9 NEIDIRECTOR’S COLUMN

NIH Neuroscience Blueprint

ecently, I on factors that control cell specializa- benefit of the broad scientific commu- Rhad the tion; signals that guide the formation nity. Eye and vision research is an inte- pleasure of par- of connections among nerve cells; and gral part of the neuroscience ticipating in the mechanisms by which experience community and has much to con- announcing the and genes work to sculpt the nervous tribute to and learn from the broader new National system. In neurodegeneration, the field. NEI is joining vigorously with the Institutes of Blueprint targets both normal aging other institutes that have a core scien- Health (NIH) and cell death due to disease and dys- tific interest in neuroscience, to make Neuroscience functional cells. In examining plastic- this initiative available to the vision Blueprint. This ity, the Blueprint emphasizes the community. This ultimately will Paul Sieving, MD, PhD is a cooperative capacity to adapt and change in enhance the study and treatment of NEI Director plan among 14 response to environmental cues, experi- visual diseases based in neurobiology NIH Institutes to foster neuroscience ence, injury and disease. and neuroscience. research. The Blueprint was unveiled at "Neuroscience" should be a com- I encourage you to examine the the Society for Neuroscience annual fortable term to the vision community. major neuroscience themes, tools and meeting in San Diego, in October We are all familiar with the term "visual resources that will become available in 2004, and is the neuroscience" the near future. Information on the “Eye and vision research is an integral part beginning of an which often is Neuroscience Blueprint can be found estimated 100 of the neuroscience community and has taken to indicate at the NIH Web Site: http://neuro- million dollar much to contribute to and learn from visual process- scienceblueprint.nih.gov/n investment in the broader field,” ing, particularly NEI Director, Paul A. Sieving, MD, PhD tools, resources, in central cir- continued from page 7 and coordinated neuroscience training cuits of the brain specifically, than the House bill. over the next five years. This initiative and visual system. In fact, however, On October 24, at the annual meet- indicates that neuroscience diseases and involvement of the eye and vision in ing of the American Academy of research into their fundamental biology the science and medicine of neuro- Ophthalmology in New Orleans, are a major priority for the NIH. science is far broader and encompasses NAEVR hosted a dinner with Over the past year, directors of 14 ocular neurobiology of diseases and Congressman Mark Foley, a member of NIH Institutes with extensive neuro- processes. the Ways and Means Committee whose science portfolios examined their Neuroscience and neurobiology are district represents the fifth largest respective research programs to identify already built into the vision commu- Medicare-eligible population in the commonalities. In addition, we invited nity through major portions of the United States. ARVO member Jean distinguished neuroscientists and neu- National Eye Institute (NEI) portfolio. Jacob, PhD described to Congressman robiologists to the NIH to comment Glaucoma research is probing mecha- Foley the importance of NEI funding on research needs and opportunities. nisms which cause the death of gan- The eye and vision community was glion cells and concomitant vision well represented at these meetings. morbidity in a sizeable portion of the Progress reports were presented to US and world population. Retinal neu- institute Advisory Councils, including rodegenerative diseases affect rod and the National Advisory Eye Council in cone photoreceptors and result in September. Since the inception of this vision loss from retinitis pigmentosa idea in early 2004 by NIH Director and macular degeneration, including Dr. Elias Zerhouni, the process has macular degeneration associated with been both challenging and rewarding. aging. Other parts of the existing NEI Photo: Congressman Mark Foley hears about grant portfolio that involve neuro- Through this effort, we have identified vision research at LSU from Dr. Jean Jacob. several cross-cutting areas of emphasis. science, neurosensory perception, and to the achievements and goals of the The 14 participating NIH institutes the neurobiology of vision include low vision research program at Louisiana have a collective budget of nearly 4.5 vision and vision rehabilitation, retinal State University. billion dollars and will devote a small cell biology and circuitry, oculomotor NAEVR is pleased to engage inter- but significant percentage of funds to systems, strabismus, amblyopia and ested ARVO members in advocacy at create additional shared resources for central visual processing. In short, the the national or local level. Contact research on three biologic themes: vision community has always had a NAEVR's James Jorkasky at 240-221- Development, Neurodegeneration, and major stake in neuroscience studies. 2905 or [email protected] Plasticity. In the area of developmental The intent of the Neuroscience biology, the Blueprint suggests focusing Blueprint is to coordinate efforts for the 10 www.arvo.org The ARVO Foundation thanks all our donors and supporters who made our accomplishments in 2004 possible. Gary Abrams Joseph Dowling Paul Lee Botir T. Sagdullaev Daniel Albert John Dowling Franklin T. Li Julie Sandell and Alcon Laboratories Henry Edelhauser Litho Ind Jeremy Wolfe Doug Anderson Jay Enoch Stuart Mangel Ramin Sarrafizadeh Joanne Angle John Epstein Rex E. Martin Ann Marie Skoczenski Sally Atherton Debora Farber Masao Matsubara Robert G. Smith Robert Barlow Frederick Ferris James McCulley Ronald E. Smith Bernard Becker Robert Frank Suzanne McKee Abe Spector and David Beebe and Israel and Diane Goldberg Joel Miller Marguerite Filson Elizabeth Beebe Richard Green Robert and Rosine Martin Steinbach Joe Besharse Karen L. Gunther Nussenblatt Mark Tso Laszlo Bito David Guyton Janice Oliva Gunter Von Noorden Janet and Robert Blanks Linda Hazlett Mildred M. G. Olivier Susan Vitale William Bourne Anita Hendrickson OPREF Jeff Walline Robert Boynton Edward Howes Daniel Organisciak Joseph Walsh Oliver Braddick Martine Jager Christopher Paterson Robert Weinreb Harvey Brown Geeta Kadambi Jacob Pe'er Sheila West David Callanan Jeffrey Kalenak Pfizer Ophthalmics Steve Wilson Oscar Candia Paul Kaufman and Harry Quigley Barry Winkler Leo Chylack Margaret George Lorin A. Riggs Agnes Wong Mandi D. Conway Ron and Barbara Klein Robert Ritch Robert Yee Cheryl Craft Stephen Klyce Retina Research Foundation Thomas Yorio Janet Davis Kirsten J. Lampi Melvin Rubin Lorenz Zimmerman Claes Dohlman Ellen Lee Stephen Ryan

Be a Part of This Exciting Chapter of ARVO's Evolution Support The ARVO Foundation With Your Donation Today The ARVO Foundation…Assuring the Future of Vision Research

The ARVO Foundation Sets Goals for 2005 Since the inception of The ARVO Foundation in grams for new researchers from outside the US can 2001, $1.75 million has been committed through be expanded. In addition to travel grants, The pledges and donations from individual and corporate Foundation plans to fund additional research awards donors. This has allowed the Foundation, while still and grants, particularly for innovative research, pilot in its infancy, to pursue a number of high-profile projects, and international research. Finally, The projects. At this years ARVO Annual Meeting, The Foundation will team with ARVO to pursue new ini- Foundation will be supporting 27 travel grants, the tiatives supporting clinician-scientists. inaugural ARVO/Pfizer Research Institute Conference To learn more about The Foundation programs, on Angiogenesis, and the first presentations of the review The Foundation Prospectus, visit www.arvofoun- ARVO/Pfizer Translational Research Award. dation.org or contact The Foundation staff at 240- For 2005, The Foundation has identified three 221-2950. You can pledge your support by sending distinct short-term program goals. Working with your donation to The ARVO Foundation, 12300 ARVO members, it is hoped that the travel grant pro- Twinbrook Parkway, Suite 250, Rockville, MD, 20852.

www.arvo.org 11 JOURNAL OF VISIONNEWS AND NOTES

Special Issue: Perception of Color

Recently Journal of Vision (JOV) completed publication of 11 articles on the theme Perception of Color and Material Properties in Complex Scenes. In their introduction, Guest Editors David H. Brainard and Laurence T. Maloney posed the question "How do human observers estimate the loca- tion, form, and color of objects?” (http://journalofvision.org/4/9/i/.) Read the articles to find out the answers and learn about recent advances in this area. The complete collection can be viewed free online at http://journalofvision.org/4/9/. As a service to the vision science community, JOV continues to publish abstracts from meetings of interest to ARVO members and those interested in vision science around the world. In 2004 JOV published the abstracts of the Vision Sciences Society meeting held April 30-May 5 in Sarasota, FL. Most recently, the full abstracts from the Optical Society of American Fall Vision Meeting, held October 14-17 in Rochester, NY, were published. You can read these abstracts at http://journalofvision.org/4/8/.n Update on Indexing

The Thomson/ISI is completing the indexing and testing of the JOV content NEW APPOINTMENTS TO as this newsletter goes to press. In January JOV articles from 2002 - 2004 BOARD OF EDITORS should be available in Web of Knowledge, Web of Science, and Current Contents. Andrew B. Watson, editor-in-chief, is In early December PsychInfo accepted JOV's content and proposal for pleased to announce six new appointments inclusion in that index! We have been advised that the only barrier to to the Board of Editors inclusion is the time it takes to index the articles. So look for the announce- Pablo Artal ment of availability late this Spring.n Universidad de Murcia, Murcia, Spain

Reviewer Randolph Blake JOV Sessions Acknowledgment Vanderbilt University, Nashville, TN

David Knill The Editor-in-Chief and the Board of University of Rochester, Rochester, NY Editors would like to publicly thank all of the people who have assisted them with Laurence T. Maloney the reviews of submitted manuscripts since New York University, New York, NY the inception of the journal. The names of John C. Palmer everyone who has completed a review since University of Washington, Seattle, WA 2001 will be included in the December 'Session' is defined as a series of clicks on a site by an issue of the journal. This acknowledgment John S. (Jack) Werner University of California, Davis, CA individual visitor during a specific period of time. A of service will become a regular feature Session is initiated when the visitor arrives at a site, and it ends when the browser is closed or there is a that will appear twice yearly - in the June The Editor-in-Chief would also like to thank period of inactivity. and December issues.n the following outgoing members of the Board for their generous support and contri- butions in both time and ideas while chart- ing the path of Journal of Vision: Barbara A. Dosher, David L. Sparks, and MILESTONES Jitendra Malik.n In November JOV reached two significant milestones: New Name Convention for 200th article was published PDF Files 400th submission was received. As a new service to our readers, each published PDF Thanks to the vision community's support, the journal is thriving! downloaded from the Journal of Vision now has a unique, meaningful filename consisting of first author's last name, the year, the journal, the volume, issue, and article numbers. For example, a recent New Staff article is McDermott-2004-JOV-4-10-9.pdf. This Welcome to Alice O'Donnell who joined the ARVO headquarters staff change is retroactive to all articles in the journal. in September as the JOV Managing Editor. Alice is responsible for all Meaningful filenames will make it easier to organize, peer-review management; quality control of submissions and final files; search, and share your personal collection of digital oversight of production and invoicing; and developing marketing, reprints. We hope this small advance will be of use to sponsorship opportunities, and communications plans for the journal. our authors and readers.n You can contact Alice at [email protected] or 240-221-2930.n 12 www.arvo.org IOVSNEWS AND NOTES

Featured Editorial in May 2005 Issue he five Editors of the leading editorial will appear in the May issue Tophthalmology and visual sci- of IOVS and will be featured on the Announcing New Editorial ence journals in the world, IOVS, ARVO Web site (www.arvo.org). An Board Members American Journal of Ophthalmology, excerpt from the draft of the Archives of Ophthalmology, policy follows. Dr. Robert Frank welcomes the following Experimental Eye Research, and "'Double publication' involves newly appointed members of the IOVS Editorial Board: Ophthalmology are issuing a "Joint repeat publication, or attempts at publication, of text, figures, or data Ted S. Acott, PhD Ophthalmic Journal Editors' Casey Eye Institute-OHSU, Portland, OR in any form of publicly available Statement on 'Double Publication'". Jayakrishna Ambati, MD Although there are no conclusive sta- media without citation in the later University of Kentucky, Lexington, KY tistics about increases in dual publi- manuscript. … As editors of major Dirk-Uwe Bartsch, PhD cation, several recent, serious journals within the fields of ophthal- Shiley Eye Center-UCSD, La Jolla, CA violations involving the above men- mology and visual science, we recog- Martine Jager, MD, PhD nize with some regret this problem Leiden University Medical Center tioned journals prompted the Editors within our profession."n Oegstgeest, The Netherlands to develop this statement. The James V. Jester, PhD Quick Facts University of California-Irvine, Irvine, CA Jeffrey W. Kiel, PhD University of Texas Health Science Center, ¨NEW in 2005 – Download Tables of Contents with links to your San Antonio, TX Personal Digital Assistant (PDA) Aize Kijlstra, PhD Wageningen University, Lelystad, The ¨4.148: #2 ranking ISI Impact Factor of 41 ophthalmology journals; Netherlands #1 is a review journal Joseph F. Rizzo, MD Massachusetts Eye & Ear Infirmary IOVS Published Manuscripts by Country, 2004 ¨#1 in ISI Immediacy Index for 2003 of Boston, MA

40 41 clinical/research ophthalmology journals Lois E.H. Smith, MD, PhD

35 Harvard Medical School/Children's Hospital,

30 ¨+7% increase in submissions over 2003 Boston, MA

25 Kazuo Tsubota, MD USA 20 ¨−27 days: Decrease in time from Keio University School of Medicine International 15 submission to publication from 2003 Shinjuku-ku, Tokyo, Japan 10 to 2004 Algis J. Vingrys, PhD 5 University of Melbourne, 0 −14 days: Decrease in time from submis- Melbourne, Victoria, Australia l r r ¨ y y h i e y t r r r r c r ay n l s e e e e a a r p u u u b b b b u ru a A M J J g m to m m n b M u e c e e a e A t J F p O ov ec Michael A. Walter, PhD e N D sion to first decision in the last 2 years S University of Alberta, Edmonton, ¨591: Total referred articles published in 2004 Alberta, Canada Christine F. Wildsoet, PhD ¨>491,000: Number of hits per month for IOVSOnline University of California-Berkeley, Berkeley, CA ¨6.9 years: Citing half-life of IOVS articlesn Sebastian Wolf, MD University of Leipzig, Leipzig, Germany Tien Y. Wong, FRCS, PhD University of Melbourne, Melbourne, 2000 - 2004 Published Articles by Section Victoria, Australia 120

100 Dr. Frank would also like to thank the 80 following people, who will be leaving 60 the Board for their diligence, thoughtful reviews, and expert recommendations 40 during the past two years: Ruben 20 Adler, MD; Joseph Caprioli, MD; Paulus de Jong, MD, PhD; Eberhard 0 Zrenner, PhD; David BenEzra, MD, AP BI CL CO EY GL IM LE PH RE RC VN VI PhD; Henry Edelhauser, PhD; and 2000 2001 2002 2003 2004 Susan Lightman, MD, PhD.n www.arvo.org 13 E X P A N D E D ARVO

he expansion of ARVO educational activities is very The symposium, Cellular Pathways in Photoreceptor Tapparent in 2005, with involvement in more than 10 Neurodegeneration, is organized by Joseph Besharse, MD. educational events beyond the Annual Meeting, including the launch of four new conferences. Under Ellyn Terry, APRIL 28-30 ARVO’s director of meetings and education, the ARVO The ARVO/Pfizer Ophthalmics Research Institute is sched- Education Group has been created to handle these exciting uled for April 28-30, supported by a generous grant to The opportunities for outreach to members and others. ARVO Foundation by Pfizer. This inau- gural conference, 2005 Ocular Versus Extraocular FEBRUARY 10-15/APRIL 28-29 The ARVO Indo-US Workshop on Angiogenesis: Mirror Images or Vague Resemblances? is organ- Collaborative Research will be held ized by Peter Campochiaro, MD. A report on the discussions February 10-15, in India, and April 28-29 and opportunities will be widely disseminated via IOVS in in Fort Lauderdale, Florida. Under a coop- late 2005. erative agreement with the National Eye PRIL Institute, these workshops will bring A 29-30 The Ninth Annual Vision Research Conference – together 40 researchers from the US and Neuroimaging the Retina – will take place April 29-30, 2005 India to discuss research opportunities in Fort Lauderdale, Florida prior to the 2005 ARVO Annual between the US and India. Five broad themes will be Meeting. Abstracts are invited for poster presentation by explored in preparation for broad dissemination of a white February 4, 2005. For further information and instructions paper on potential collaborative areas: on how to submit an abstract, visit www.visionresearch-con- • Molecular Genetics of Eye Disease ference.elsevier.com or contact [email protected]. • Clinical Aspects of Genetics of Eye Disease The conference is organized and hosted by Elsevier/Vision • Harmonization of Clinical Measurement Techniques and Research and is co-sponsored by ARVO. Terminology for Targeted Diseases and Structures • Identification, Development and Exchange of Research SEPTEMBER 8-10 Resources ARVO is pleased to announce the inaugural Summer Eye • Translational Physiology: Bench to Bedside Research Conference, Ocular Cell and Molecular Biology, Application September 8-10, 2005, in Sarasota, Site visits to several Indian research institutes are planned. Florida, at the Colony Resort, right on the For details, see the Web site at beach. Conference attendance is limited. www.arvo.org/india/index.asp. The conference, organized by Steven E. Wilson, MD, and Joe G. Hollyfield, PhD, FEBRUARY 16-20 will feature several keynote speakers, ARVO is cosponsor for the 2nd SERI-ARVO Meeting on including David Beebe, PhD; Elizabeth Research in Vision and Ophthalmology in Singapore, Fini, PhD; William Hauswirth, PhD; February 16-20, www.seri.com.sg. Plan to attend the ARVO Leonard A. Levin, MD, PhD; Kris sponsored symposium organized by Elizabeth Fini, MD, Hot Palczewski, PhD; and Mansoor Sarfarazi, Topics in Eye and Visions Research, on February 17, 1:00 PM - PhD. Save the date and add your name to 4:00 PM. the mailing list today by contacting www.arvo.org/ocmb [email protected]. (See page 22 for more details.) MARCH 18-21 ARVO is sponsoring a symposium at the Pan-American SEPTEMBER 25-28 Association of Ophthalmology's (PAAO) XXV Panamerican The 2005 ARVO Western Eye Research Congress, March 18-21, 2005, in Santiago Chile. Clinical Conference, Regenerative Ocular Biology: Applications of Retina Research, organized by Gary Abrams, Restoring Vision in the Aged & Diseased Eye, MD, is scheduled Saturday, March 19, 8:00 AM - 9:30 AM. will be held September 25-28 in Laguna www.arvo.org/werc ARVO is also cosponsoring the PAAO pre-ARVO Day, Beach, California, at the beautiful Surf and Sand Resort. The Saturday, April 30, 2005, in Fort Lauderdale, Florida. For plenary speaker is Fred H. Gage, PhD. Featured keynote details, check the ARVO Web site, www.arvo.org. speakers include Mark WJ Ferguson; Mark Humuyan, MD, PhD; Mark Keating; Robert Lavker, PhD; Bjorn R. Olsen, APRIL 2-6 MD, PhD; and Jim Zieske, PhD. To be placed on a mailing ARVO is cosponsoring a symposium at list for more information, please send your name and e-mail the American Association of address to [email protected]. (See page 21 for more details.) Anatomists Annual Meeting on April 4, from 2:30 PM - 4:30 PM in Room 23 of the San Diego Convention Center. ARVO educational activities continued on next page 14 www.arvo.org EDUCATIONAL EVENTS

ARVO educational activities continued from previous page 2006 OCTOBER 5-8 ARVO will sponsor a sym- FEBRUARY 20-24 posium at the 2005 The XXX International Congress of Ophthalmology will be European Association for held February 20-24, 2006 in Sao Paulo, Brazil. ARVO will Vision and Eye Research sponsor two symposia on the topics of Technology in (EVER) Annual Meeting, October 5-8, 2005, in Vilamoura, Ophthalmology and Progress in Gene Therapy. For further Portugal. EVER will, in turn, organize a symposium for pres- details, see the conference Web site at entation at the 2006 ARVO Annual Meeting. www.ophthalmology2006.com.br/.n

2006 ARVO/PFIZER OPHTHALMICS 2006 ARVO SUMMER EYE RESEARCH CONFERENCE RESEARCH INSTITUTE CALL FOR PROPOSALS CALL FOR PROPOSALS ARVO is currently soliciting proposals from individuals or institutions wish- ing to serve as the organizer of a 2006 ARVO Summer Eye Research Proposals are now being solicited for the 2006 Conference. The ARVO Summer Eye Research Conferences have been devel- ARVO/Pfizer Ophthalmics Research Institute, oped to provide members an opportunity to meet with colleagues on a nar- scheduled for April 27-28, 2006, on the topic of row interdisciplinary topic, promote discussion and free exchange of ideas, Aqueous Humor Outflow: What Do We Know, explore new approaches in research areas, and stimulate advanced research. Where Will It Lead Us? Proposals are due February At least one ARVO Summer Eye Research Conference will be scheduled 15, 2005. For details, visit The ARVO Foundation between July 1, 2006 and October 1, 2006. The proposal deadline is March Web site at www.arvofoundation.org.n 1, 2005. You must be an ARVO member to submit a conference proposal. For details and proposal guidelines, go to www.arvo.org/serc or contact Ellyn Terry, [email protected], 240-221-2935.n

Special Announcement on the Women’s Eye Health Task Force

he Women's Eye Health Task reason, in industrialized countries, age- WOMENS EYE HEALTH TForce (WEHTF) was formed in related eye diseases such as macular response to prevalence of blindness and degeneration (AMD) and cataract TASK FORCE visual impairment in women. affect more women than men. These Given the burden of blindness in Rates of blindness and visual conditions may be exacerbated by women, the Women’s Eye Health Task impairment are higher in women, in lifestyle factors. For example, 30 per- Force (WEHTF) was founded in 2002. most age groups, worldwide. In 2001, cent of AMD and cataract may be The WEHTF, based at the Schepens a meta-analysis of associated with smoking. Eye Research Institute, is dedicated to more than 70 popula- Some eye diseases protecting the sight of women and tion-based surveys of are, however, intrinsi- their families and is committed to blindness revealed a cally prevalent in reducing the burden of blindness and previously unknown, women. These include visual impairment through advocacy and still largely certain types of for women’s eye health issues, unpublicized, fact – of cataract, dry eye syn- through educational outreach to the all blind and visually- drome (a common eye public concerning prevention and impaired persons condition two to three treatment of eye disease and by rais- throughout the world, times more prevalent ing awareness within professional two-thirds are women. in women) and organizations of women’s eye health In the US alone, more autoimmune diseases issues. In addition, the WEHTF is than 3.4 million peo- such as Sjögren's syn- developing international partnerships, ple have visual impairment (including drome, that have ocular manifesta- to advocate for eye health programs blindness), of these approximately 2. 3 tions. that recognize the greater burden of million are women. Outside industrialized countries, blindness and visual impairment in What accounts for the gender dif- both cataract and trachoma are more women, and undertake special efforts ference? Research continues but at common in women, and lack of access to reach this population. Y ou can learn least three factors contribute to the dis- to information and eye care services more about women’s eye health and parity. Blindness increases with age and has been suggested as an important the Women’s Eye Health Task Force at women live longer than men. For this reason for this disparity.n www.womenseyehealth.org/n www.arvo.org 15 G R A N T S AND

Tear Film & Ocular Surface Society Travel A wards Applicant s Wanted

he Tear Film & Ocular Surface Dinner on the evening of Monday, Word file of the abstract with the TSociety (TFOS) seeks applicants May 2 in Fort Lauderdale. graphic inserted below. The figure for the annual TFOS Travel Awards. To apply, please e-mail your should demonstrate evidence of the These awards provide partial travel accepted ARVO abstract plus one PDF, abstract's most important finding, support to the ARVO Annual Meeting TIFF, JPEG or PowerPoint figure to and will be held in strict confidence by for at least four postdoctoral Lydia Briscoe at [email protected] the awards committee. fellows, graduate students or young before April 4, 2005. Send either as Awardees will be notified by April investigators (35 years or two separate files, or better as a single 25 and will be announced during younger) whose ARVO 2005 abstract the TFOS Cruise & Dinner. 2005 in which they appear as first author ARVO travel grant award winners are demonstrates significant scientific not eligible. For more information achievement in the field of tear about these awards or the cruise, film, ocular surface or Sjogren's syn- please contact Amy Sullivan at drome research. Each award is [email protected] $750.00 and will be accompanied by a free ticket to the TFOS Cruise &

ARVO 2004-2005 Research Fellowship Grants

he ARVO Research Fellowship Grant Program, established in 1987 with Fight for Sight Tone Alcon Laboratories grant, continues to be generously supported by Research Grant A wards Alcon, Novartis Ophthalmics, and the Japan National Society for the A vailable Prevention of Blindness. Recipients are selected from candidates who apply for the Fight for Sight Awards, for which ARVO conducts the scientific review. ARVO IS PLEASED TO ANNOUNCE THE RECIPIENTS OF THE 2004-2005 GRANTS:

For the 2005-2006 year, the deadline for the grants-in-aid and the postdoctoral research fellowship will be ARVO/Weisenfeld Fund Japan National Society for the March 1, 2005. Mohamed Al-Shabrawey Prevention of Blindness Medical College of Georgia Hiho Nozaki, MD, PhD Project Title: Diabetes-Induced Vascular University of Kentucky The summer student award Permeability: Role of NADPH Oxidase Project Title: Proteome Mapping of Cc12-/ deadline has been moved to and Ccr2-/- Mouse Models of AMD February 1, 2005.

Visit the Web site, www.fightforsight.com for instructions and copies of the new application.

Novartis Pharmaceuticals Corporation Alcon Laboratories See page 18 for a complete Judith Sabah, PhD, Kent State University Incorporated Research Grant list of 2004-2005 Magdalena Stanizewska, PhD Project Title: Mechanisms of Internaliza- award recipients.n tion of Albumin and Determination of the Case Western Reserve University Protein Function in the Lens Project Title: Protein Modification by Tryptophan Oxidation Products in the 16 Human Lens www.arvo.org AWARDS 2006 ARVO Annual Awards Call for Nominations

Nomination Deadline: March 4, 2005 ARVO/Pfizer Ophthalmic Translational Research Members of the vision community are invited to nominate Award their esteemed colleagues for the prestigious ARVO Awards Excellence in research and fundamental scientific discoveries, to be presented at the 2006 ARVO Annual Meeting. concepts and novel technologies that lead to the diagnosis, prevention or amelioration of the pathological eye and/or an Proctor Medal understanding of the normal vision processes. Outstanding research in the basic or clinical sciences as applied to ophthalmology. Kupfer Award Distinguished public service on behalf of eye and vision Friedenwald Award research. Outstanding research in the basic or clinical sciences as applied to ophthalmology. Special Recognition Award Outstanding service to the vision research community. Mildred Weisenfeld Award for Excellence in Ophthalmology Distinguished scholarly contributions to the clinical practice of ophthalmology. For complete nomination and award Cogan Award information, please visit our Web site at Contributions to research in ophthalmology or visual sciences www.arvo.org/AwardsFunding/ directly related to disorders of the human eye or visual system, awardnom.asp. You can also contact Barbara by a promising individual researcher under 40 years of age. Hollis at [email protected] or 240-221-2940.n

PREVENT BLINDNESS AMERICA ANNOUNCES A NEW OPPORTUNITY FOR RESEARCHERS:

PREVENT BLINDNESS AMERICA INVESTIGATOR AWARD

The Prevent Blindness America Investigator Award provides funding for clinically-based research investigating public health issues related to the burden of illness of eye-related health and safety topics. All research grants must focus on preserving sight and preventing blindness.

Researchers will be chosen based on their level of qualifications relating to the eye health field and the quality and feasibility of the proposed research project. Researches must demonstrate a high level of academic achievement, the urgency of the research agenda and show an immediate human benefit. Research pertaining to prevalence, early detection strategies and outcomes and prevention will take priority.

AWARDS: Grants will be awarded for $25,000.00 to $50,000.00 each for a one-year period. Grants are only available to United States citizens. Up to a total of $100,000.00 will be granted annually. The number of awards depends on the dollar amount of the grants awarded. Grant recipients will be required to submit quarterly progress reports. The Association for Research in Vision and Ophthalmology will provide the scientific review of grant applications.

DEADLINE: All grant applications must be submitted by March 1, 2005.

APPLICATION PROCESS: Applications are available at www.preventblindness.org/research.

www.arvo.org 17 M O R E GRANTS AND

Fight for Sight Grant s and Fellowship s

ight for Sight is pleased to announce that it has awarded Grants-in-Aid Fmore than $600,000 in grants and fellowships for 2004- Miriam Benezra, PhD; Anissa Buckner, PhD; Richard 2005. Individual awards included: 19 grants-in-aid, 15 post- Chappell, PhD; Nigar Fatma, PhD; Kristen Huang, PhD; doctoral research fellowships and 37 summer student Wei Li, PhD; Frank Liang, MD, PhD; Gregory Liou, PhD; fellowships. Support for the pediatric eye services at six insti- Manuel Llano, MD, PhD; Jeffrey Marchant, PhD; Royce tutions was also announced. Mohan, PhD; Robert Nickells, PhD; The Fight for Sight Scientific Kouros Nouri-Mahdavi, MD; Sanjay Awards are selected under the direc- Rao, MD; Gabriele Richard, MD; tion of the Association for Research Theodore Schurr, PhD; Gail Seigel, in Vision and Ophthalmology. The PhD; John Ubels, PhD; Xuemei Awards Selection Committee is lead Zhu, MD. by Henry Edelhauser (Emory University) and Randy Kardon Postdoctoral Research Fellowships (University of Iowa). We wish to Vicki Bennett, PhD; Lucy Chen, acknowledge the participation and MD, PhD; Bogdan Gugiu, PhD; contributions of the following members of the review com- Sharon Haymes, PhD; Wei Li, PhD; Toshiyuki Oshitari, mittee: Jay Ambati; Usha Andley; Sally Atherton; Jimmy MD, PhD; Boris Ovodenko, MD; Katalin Rabl, PhD; Bartlett; Barbara Battelle; Curtis Brandt; Ruth Caldwell; Daniel Shurman, MD; Jim Stringham, PhD; Jing Tian, Michelle Callegan; Edward Chaum; Alan Franklin; Enrique PhD; Abhiram Vilupuru, PhD; Christine Watte, DVM; Garcia; Marion Gordon; Anne Griep; Linda Hazlett; Zhaohong Yin, MD; Tian-Yi Zhang, PhD. Richard Hertle; Andrew Huang; Kelly Hutcheson; Karen Joos; Nancy Joyce; Maureen McCall; Machelle Pardue; Summer Student Fellowships Matthew Petroll; Stephen Planck; Gail Seigel; Susan Semple- Saba Ali; Afshin Arianjam; Chirag Bhatia; Christina Cheng; Rowland; Diane Song; Janet Sparrow; Om Srivastava; Kristina DeSmet; Michael Engles; Sherry Hikita; Karlo Michael Stern; Stephen Tsang; John Ubels; Barbara Wiggert; Hockmann; Wandu Hu; Arif Ishmael; Kapil Kapoor; Pearl and Matthew Wilson. Their contribution to this effort is Kurian; David Myung; Hung Nguyen; Rachel Peck; Peter invaluable. Polewski; Kristin Rarey; Christopher Schultz; Vincent Fight for Sight will increase funding for grants-in-aid and Scoglietti; Nancy Sorokac; Rebeca Tenney; Kristen postdoctoral fellowships to $20,000 per award in 2005. No Thorstenson; Elaine Trieu; Felix Vazquez-Chona; Baotran more than three years should have elapsed since the awarding Vo; Kurt Weaver; William Yang. of a degree to those applying for a postdoctoral research fel- lowship. Fellow candidates need not be American citizens, Support for Pediatric Eye Centers but the research must take place in the US or Canada. Bascom Palmer Eye Institute/Fight for Sight Children's Eye Grants-in-aid are awarded to investigators for pilot projects Clinic; Children' Hospital of the University of and studies without other sources of funding. Pittsburgh/Fight for Sight Children's Eye Clinic; University For the 2005-2006 year, the deadline for the grants-in-aid of Tennessee, Department of Ophthalmology, Study on and the postdoctoral research fellowship will remain March 1, Shaken Impact Syndrome; University of Wisconsin - Division 2005. The summer student award deadline has been moved of Pediatric Ophthalmology; Memorial Sloan Kettering to February 1, 2005. Visit the Web site, Ophthalmic Oncology Center; University of Alabama - www.fightforsight.com for instructions and copies of the new Birmingham, Division of Pediatric Ophthalmology.n application.

FIGHT FOR SIGHT AWARDS FOR THE YEAR 2004-2005 19 GRANTS-IN-AID $222,505 15 POSTDOCTORAL RESEARCH FELLOWSHIPS $240,000 37 SUMMER STUDENT FELLOWSHIPS $ 56,700 6PEDIATRIC SUPPORT GRANTS $ 83,000 77 TOTAL AWARDS $602,205

18 www.arvo.org AWARDS Cora Verhagen Prize

he Cora Verhagen Prize is awarded for the best ocular immunology poster or paper presentation at the ARVO Annual TMeeting. The Cora Verhagen Prize was instituted in 1995 to honor the memory and scientific contributions of our colleague Cora Verhagen. An international jury committee consisting of six active ARVO members has been appointed to select the Prize Winners. Two prizes will be awarded. The first prize winner will receive an award of $250 and a plaque with an inscription of his or her name along with those of previous awardees. This plaque may be temporarily mounted in the institute in the year following the presentation at ARVO. The winner will also receive a bronze medallion. Both the medallion and the plaque contain the image of Winged Victory. The money and the plaque for the 2005 Cora Verhagen Prize will be awarded at the 2006 ARVO Annual Meeting. The second place winner will receive an award of $100.

1. Eligible candidates for the prize should conform to the following criteria: Candidates must be a student or postdoctoral fellow considered as a trainee in ocular immunology working under the guidance of a mentor. Such trainees may have independent support for salaries, but do not hold a personal grant to support the cost of their research. Excluded are individuals with permanent faculty appointments at universities, research institutes, or employees of companies.

2. Candidate must be the first author of a poster or paper presentation at the 2005 ARVO Annual Meeting dealing with a subject in the field of ocular immunology.

Call for Applications deadline is April 1, 2005. Please send all Application Forms to: Dr. Martine Jager Department of Ophthalmology LUMC-J3 PO Box 9600 2300 RC Leiden The Netherlands Fax: 31-71-5248222 E-mail: [email protected]

DO NOT SEND APPLICATION FORMS TO THE ARVO OFFICE.

APPLICATION FORM

CORA VERHAGEN PRIZE I WOULD LIKE TO COMPETE FOR THE 2005CORA VERHAGEN PRIZE TO BE AWARDED FOR THE BEST "OCULAR IMMUNOLOGY" PRESENTATION BY A TRAINEE.

Name: ______

Abstract Title: ______

Mentor Name: ______

Mentor Statement: I hereby state that the above named applicant fulfills the "trainee" criteria for the Cora Verhagen Prize.

Mentor Signature: ______

www.arvo.org 19

Regenerative Ocular Biology Restoring Vision in the Aged & Diseased Eye SEPTEMBER 25-28, 2005 LAGUNA BEACH, CALIFORNIA – SURF AND SAND RESORT

Organizers: James V. Jester, University of California, Irvine and Corinne G. Wong, SCLERA, LLC

PRELIMINARY SCHEDULE SUNDAY TUESDAY September 25, 2005 September 27, 2005 4:00 PM 8:30 AM Plenary Speaker: Fred H. Gage, PhD, The Salk Institute Session IV: Scarless Wound Healing: Session I: Stem Cell Biology Taming of the Screw Keynote Speaker: Robert Lavker, PhD Keynote Speaker: Mark W.J. Ferguson, BSc, DDS, PhD, FFD, FMedSci, CBE (Sponsored by the Discovery MONDAY Fund for Eye Research, University of California, Irvine) September 26, 2005 8:30 AM 4:00 PM Session II: Control of Cell Growth and Differentiation by Session V: Bio-mimetic Systems/Artificial Gene Transfer Retina and Cornea Keynote Speaker: Keisuke Mori, MD (tentative) Keynote Speakers: Mark Humuyan, MD, PhD and Jim Zieske, PhD 1:30 PM Session III: Regenerative/Developmental Biology WEDNESDAY Keynote Speaker: Mark Keating, PhD September 28, 2005 8:30 AM Session VI: Biomodulators of Cell Growth, Differentiation and Function Keynote Speaker: Bjorn R. Olsen, MD, PhD

FOR MORE INFORMATION visit www.arvo.org/werc or contact Rhonda Williams, meeting coordinator, at [email protected] or 240-221-2908. ARVO Western Eye Research Conference presented by

The Association for Research in Vision and Ophthalmology • 12300 Twinbrook Parkway • Suite 250 • Rockville, MD • 20852-1606 • USA ORGANIZERS: Steven Wilson and Joe Hollyfield Cleveland Clinic

Keynote Speakers: Invited Speakers: David Beebe, PhD Gustavo D. Aguirre, VMD, PhD Conditional Gene Targeting Reveals Functions for Many Robin R. Ali, PhD Growth Factor Signaling Pathways in Anterior Segment Robert (Gene) Anderson, MD Development Nick Bazan, MD Joe C. Besharse, PhD Elizabeth Fini, PhD John Crabb, PhD Matrix Metalloprotenases in the Eye Cheryl Craft, PhD William Hauswirth, PhD Stephen Daiger, PhD Gene Therapy for Dominant, Recessive and Adriana Di Polo, PhD X-linked Retinal Diseases in Animal Models Anne E. Griep, PhD Leonard A. Levin, MD, PhD Joe G. Hollyfield, PhD Axonal Signaling of Retinal Ganglion Cell Death James Jester, PhD Winston Kao, PhD Kris Palczewski, PhD Andrius Kazlauskas, PhD Chemistry of Vision: Inherited Retinal Diseases Dan Organisciak, PhD and Rhodopsin David Papermaster, PhD Mansoor Sarfarazi, PhD Steven E. Wilson, MD Gene Identification and Protein Characterization Donald J. Zack, MD of Glaucoma-Causing Molecules James Zieske, PhD FOR MORE INFORMATION visit www.arvo.org/ocmb or contact Rhonda Williams, Meeting Coordinator, at [email protected] or 240-221-2908.

ARVO Summer Eye Research Conference presented by

The Association for Research in Vision and Ophthalmology • 12300 Twinbrook Parkway • Suite 250 • Rockville, MD • 20852-1606 • USA

22 www.arvo.org 2005 Membership Application Join/Renew Online: www.arvo.org

Assocation for Research in Vision and Ophthalmology • 12300 Twinbrook Parkway • Suite 250 • Rockville, MD 20852-1606• Phone: (240) 221-2900 • Fax: (240) 221-0370

MEMBER INFORMATION (please write legibly) SCIENTIFIC SECTION AFFILIATION

q New Member Candidate* q Renewing Member ID# Check the two-letter code for the Scientific Section that best fits your research. (Descriptions are on the back of this form.) First Name Middle Last (Surname/Family) Name q AP q BI q CL q CO q EY q GL q IM q LE Degree(s) q PH q RE q RC q VI q VN Department MEMBER DEMOGRAPHICS This is optional and confidential Organization/Institution (For ARVO programmatic purposes only) US CITIZEN q Yes q No Street Address GENDER q Male q Female City State/Province Zip+4/Postal Code Country YEAR OF BIRTH ETHNICITY Phone Fax q Native American/Alaskan Native q Asian E-mail (required) q NativeHawaiian/Pacific Islander q Hispanic *Endorsement of Candidate for Membership (Required of All New Member Candidates) q Black (not African American) q African American q White (not of Hispanic origin) Endorser’s Signature Endorser’s Printed Name Member Number (Contributing, Fellows and Predoctoral Members may not endorse)

JOURNAL SUBSCRIPTION (Does not apply to Members-in-Training, categories F and P)

All memberships include free access to full-text online of IOVS and JOV, regardless of selections indicated below. $100 of your dues supports the ARVO journals. Please select the journal to which you would like your dues allocated.

q Investigative Ophthalmology & Visual Science (IOVS) OR q Journal of Vision (JOV) If you have selected IOVS, do you want to receive the print format? q Yes q No 2005 ANNUAL DUES PAYMENT

MEMBER CATEGORIES & DUES (Descriptions are on the back of this form.) Please check the appropriate Membership Category and enter the corresponding amount on the Total line. Dues for all membership categories, except Life and Life Family, are for the 2005 calendar year.

q Regular (R) $195 q Family (R-FAMJ) $225 Total Remittance $ q Sustaining (R-SUS) $250 Payment must accompany form. Purchase orders will not be accepted. q Contributing (R-CON) $250 q Life (LIFE) $3,950 qCheck enclosed made payable to ARVO (US dollars drawn on a US bank) q Life Family (LIFEFAM) $4,950 q Fellow, Resident, or Other qPlease charge my: q Visa q MasterCard Postdoctoral Student (F)* $85 (with IOVS $185) q Predoctoral Student (P)* $85 (with IOVS $185) Account Number: *Student Status Certification (Required). I certify that during 2005 I will have full-time status. Expiration Date:

Supervisor’s Signature Printed Name/Title Signature:

Institution/Department ADDITIONAL INFORMATION: wMeeting Registration Fees are NOT Included wMembership Dues are non-refundable wARVO’s Federal ID Number is 34-0812556 YOUR 2005 DUES PAYMENT MUST BE RECEIVED AND PROCESSED TO ACCESS ABSTRACT SUBMISSION. ABSTRACT DEADLINE:DECEMBER 3, 2004 www.arvo.org 23 Check out the NEW and IMPROVED ARVOJobs jobs.arvo.org The Best Source for Ophthalmology and Vision Research Jobs & Resources

JOB SEEKERS EMPLOYERS • Scan scores of jobs available – For FREE • Get great exposure among job seekers • Target your search by job category, • Access an online database of CVs from location, and salary level qualified candidates • Register to receive E-mails when a position • Register to receive E-mails when a matching your criteria is posted candidate matching your criteria is • Post your CV for FREE for employers to posted review • Enjoy competitive job-posting rates

ARVOJobs is an online service located at jobs.arvo.org. For ARVO Members, the rate for posting jobs is $200.00 for a 30-day listing; Nonmembers pay $300.00.

For more information, visit the Web site jobs.arvo.org, E-mail [email protected], or call 240-221-2940. jobs.arvo.org

2005 CAREER FAIR Sign up to participate in the 2005 ARVO Career Fair, held in the registration area on Tuesday, May 3 from 12:00 to 4:00 pm. Don’t miss this great opportunity to meet face-to- face with employers and employees! See www.arvo.org/AM/CareerFair.aspx